The Spectrum of MDS: Disease Management and Patient Education

Estimated Time
1.50 hours

Release Date
Jun 15, 2021

Expiration Date
Jun 14, 2022

This program was recorded at the ONS Congress on April 29, 2021 and is targeted to clinical nursing professionals in oncology. 

Instructions for Credit

There are no fees for participating in or receiving credit for this accredited CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is accredited for 1.5 continuing education credit for nurse practitioners and nurses. In order to receive credit, learners must participate in the entire accredited CE activity. Completion of the post-test and evaluation are required in their entirety and a score of 70% or higher is needed to obtain Nursing Continuing Professional Development (NCPD) contact hours. Once submitted, the certificate will be automatically generated as a PDF online

Please retain a copy of the certificate for your records.  For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or

You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.  

Medical Learning Institute, Inc. and  Aplastic Anemia & MDS International Foundation are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this accredited CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and Aplastic Anemia & MDS International Foundation.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.


Accreditation and Disclosure Information

Target Audience
This accredited CE activity is intended for nurses and nurse practitioners engaged in the care of patients with with myelodysplastic syndromes (MDS).
Educational Objectives
    After completing this accredited CE activity, the participant should be better able to:
  • Explain the methods used to diagnose, stratifying and treat MDS
  • Identify current and emerging treatment options for patients with low-risk MDS, high-risk MDS, and secondary AML
  • Analyze the nurse's role in managing treatment for MDS based on clinical presentations diagnostic workups, transfusion dependence, comorbidities, and clinical trial considerations
  • Discuss strategies to address treatment goals and decision-making, educate patients, and provide palliative care to improve outcomes
Accreditation Credit and Support
This NCPD activity is provided by Medical Learning Institute, Inc.
Educational Partner Statement
This activity is developed with our educational partner, Aplastic Anemia and MDS International Foundation.
Commercial Support Statement
This accredited CE activity is supported by independent educational grants from Bristol Myers Squibb and Gilead Sciences, Inc.
Nursing Continuing Professional Development (NCPD)
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours and 1.12 contact hours in the area of pharmacology.

Nurse Practitioner Credit Designation (AANP)
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 21054933. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality accredited continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this accredited CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME,  as related to the content of this accredited CE activity, regardless of the amount or their view of the relevance to the accredited education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the accredited CE activity. 
Catherine Chittick, RN, BSN, BMT/Leukemia Team, Massachusetts General Hospital Cancer Center, Boston, MA
Catherine Chittick, RN, BSN, BMT, Faculty/Planner, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Jenna Moran, MSN, FNP-BC, Leukemia Team, Massachusetts General Hospital Cancer Center, Boston, MA
Jenna Moran, MSN, FNP-BC, Faculty/Planner, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Aura Ramos, RN, BSN, Leukemia Team, Massachusetts General Hospital Cancer Center, Boston, MA
Aura Ramos, RN, BSN, Faculty/Planner, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider and Aplastic Anemia & MDS International Foundation, our educational partner, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this accredited CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this accredited CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this accredited CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.







Aplastic Anemia and MDS International Foundation Resources

                   Patient Referral form

                   Diagnostic Spectrum of MDS, MDS/MPN and MF Card

Information Resource Specialists:
Assist through treatment, financial & social challenges, and give treatment and support information.
      Phone: (800) 747-2820, option 2. M-F, 8 am to 4 pm ET
      Live chat:

                Talk with a volunteer   

                 Become a volunteer

                 Join or Start a Community Connections Support Group